Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Korean Circ J · 2012 · PMC3369963 · PMID 22701134

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Effect of rate of reduction of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes at 12-month Reduction rate of non-HDL-C showed a decreasing trend of 12-month MACE, but it was not statistically significant {43.8% reduction in group A (0-10%) vs. 26.7% in group B (10-30%) vs. 19.0% in group C (>30%), p=0.069} as shown in Fig. 2 .

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.